IMPROVED GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES

Clinical trials for IMPROVED GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES explained in plain language.

Never miss a new study

Get alerted when new IMPROVED GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES trials appear

Sign up with your email to follow new studies for IMPROVED GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Kidney function and drug processing: a closer look

Knowledge-focused Completed

This study looked at how the drug HR17031 is processed in people with different levels of kidney function, from mild to severe kidney disease and even end-stage disease. It included 24 adults aged 18 to 70. The goal was to measure drug levels in the blood, not to treat diabetes. …

Matched conditions: IMPROVED GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES

Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Knowledge-focused

Last updated May 26, 2026 11:31 UTC

IMPROVED GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES

Get alerted when new IMPROVED GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES trials appear

Kidney function and drug processing: a closer look